ReviewVaccine2016
Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.
Rashmi Dixit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it